C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2002
10/17/2002	CA2442839A1 Production and use of novel peptide-based agents for use with bi-specific antibodies
10/17/2002	CA2442817A1 Implantation serine proteinases
10/17/2002	CA2442739A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/17/2002	CA2442685A1 Estrogen receptor-related receptor alpha (err.alpha.) and cartilage formation
10/17/2002	CA2442651A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/17/2002	CA2442574A1 Novel proteins and nucleic acids encoding same
10/17/2002	CA2442386A1 Epitope sequences
10/17/2002	CA2442096A1 Methods for the preparation of polynucleotide librairies and identification of library members having desired characteristics
10/17/2002	CA2442092A1 Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication
10/17/2002	CA2441633A1 Fragment of l. lactis plasmid conferring antiphage activity and uses thereof
10/17/2002	CA2441628A1 Alpha-galactosidase as food-grade genetic marker
10/17/2002	CA2440845A1 New method
10/17/2002	CA2440219A1 Proteins, polynucleotides encoding them and methods of using the same
10/17/2002	CA2439503A1 Recombination super compound interferon used as hepatitis b surface antigen and e antigen inhibitor
10/17/2002	CA2439342A1 Oryza sativa nuclear cap binding protein 80
10/17/2002	CA2439111A1 Mucosal boosting following parenteral priming
10/17/2002	CA2436805A1 Cell cycle nucleic acids, polypeptides and uses thereof
10/17/2002	CA2436278A1 Method for the detection of cytochrome b mutations in fungi
10/17/2002	CA2435528A1 Novel polypeptides and nucleic acids encoded thereby
10/17/2002	CA2433463A1 Computer-directed assembly of a polynucleotide encoding a target polypeptide
10/17/2002	CA2429376A1 Mitogenic oxygenase regulators
10/17/2002	CA2382246A1 Reaction apparatus and method of analyzing biologically active substances using the same
10/16/2002	EP1249705A2 Multiplexed molecular analysis apparatus and its fabrication method
10/16/2002	EP1249502A2 Beads, preparing method for the same, flow cytometer and program
10/16/2002	EP1249498A2 Alzheimer's disease secretase, APP substrates therefor, and uses therefor
10/16/2002	EP1249497A2 Methods for calcium phosphate transfection
10/16/2002	EP1249496A2 Methods for producing and transforming cassava protoplasts
10/16/2002	EP1249495A1 Murine DNase X, pharmaceuticals containing thereof and non-human mammal with modified DNase X-gene
10/16/2002	EP1249494A1 Process for the biological production of l-pipecolic acid
10/16/2002	EP1249493A1 Rice peroxidases with various characteristics
10/16/2002	EP1249492A2 Antibodies against an adrenergic receptor
10/16/2002	EP1249491A2 Human very long chain acyl-CoA synthase (VLCAS)-like protein and nucleic acids encoding it
10/16/2002	EP1249490A2 In vitro activation of cytotoxic T cells
10/16/2002	EP1249456A1 Novel peptide and screening method by using the same
10/16/2002	EP1249160A1 Model animal with favorite onset of rheumatoid arthritis
10/16/2002	EP1248860A2 Barcoded synthetic lethal screening to identify drug targets
10/16/2002	EP1248859A1 Method for synthesising and immobilising nucleic acids on a silanized solid support
10/16/2002	EP1248858A1 Antisense modulation of caspase 8 expression
10/16/2002	EP1248856A2 Screening method for nucleic acids
10/16/2002	EP1248854A1 rpoB GENE FRAGMENTS AND A METHOD FOR THE DIAGNOSIS AND IDENTIFICATION OF MYCOBACTERIUM TUBERCULOSIS AND NON-TUBERCULOSIS MYCOBACTERIAL STRAINS
10/16/2002	EP1248852A2 Method of assessing the viability of a cell
10/16/2002	EP1248851A2 Canine adenovirus vectors for the transfer of genes in targeted cells
10/16/2002	EP1248850A2 Root-preferred promoter elements and methods of use
10/16/2002	EP1248849A1 Obg3 globular head and uses thereof for decreasing body mass
10/16/2002	EP1248847A1 Irak-4: compositions and methods of use
10/16/2002	EP1248846A2 Human kinase protein and polynucleotides encoding the same
10/16/2002	EP1248845A1 Specific fruit- plant promoter
10/16/2002	EP1248844A1 Analogs of human basic fibroblast growth factor
10/16/2002	EP1248843A2 Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses
10/16/2002	EP1248842A1 2871 receptor, a g-protein coupled receptor and methods of use thereof
10/16/2002	EP1248841A2 Genes differentially expressed in breast cancer
10/16/2002	EP1248840A2 Circularly permutated, interaction-activated proteins
10/16/2002	EP1248838A1 Polyampholytes for delivering polyions to a cell
10/16/2002	EP1248837A2 Angiotensin converting enzyme homolog and its use
10/16/2002	EP1248836A2 Hybrid cells obtainable from antigen presenting cells
10/16/2002	EP1248835A2 Genetically modified fibroblast cell
10/16/2002	EP1248813A2 Antisense antibacterial cell division composition and method
10/16/2002	EP1248804A2 Recombinant antibodies to human interleukin-1 beta
10/16/2002	EP1248803A2 Nogo receptor-mediated blockade of axonal growth
10/16/2002	EP1248802A2 Soluble ctla4 mutant molecules and uses thereof
10/16/2002	EP1248801A1 Human polynucleotides, polypeptides, and antibodies
10/16/2002	EP1248798A2 Human dna sequences
10/16/2002	EP1248795A1 Antisense modulation of macrophage migration inhibitory factor expression
10/16/2002	EP1248794A1 Antisense modulation of smad7 expression
10/16/2002	EP1248793A1 Polynucleotides for inhibiting metastasis and tumor cell growth
10/16/2002	EP1248792A1 Antisense modulation of peroxisome proliferator-activated receptor gamma expression
10/16/2002	EP1248791A1 Antisense modulation of caspase 3 expression
10/16/2002	EP1248679A2 Method for isolating proteins or protein and nucleic acid associations, or particle and protein complexes, reagent and uses
10/16/2002	EP1248654A2 Intra-tumoral administration of il-12 encoding nucleic acid molecules
10/16/2002	EP1248653A2 Gene therapy to promote angiogenesis and/or the treatment of heart failure
10/16/2002	EP1248650A2 Improved dna vaccines for production-type animals
10/16/2002	EP1248646A2 Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another enteric pathogen
10/16/2002	EP1248645A1 Novel chimeric proteins and methods for using the same
10/16/2002	EP1248635A1 Antisense modulation of glycogen synthase kinase 3 alpha expression
10/16/2002	EP1248634A1 Antisense modulation of mekk2 expression
10/16/2002	EP1248633A1 Antisense modulation of glycogen synthase kinase 3 beta expression
10/16/2002	EP1248631A1 Methods for inhibiting/treating hiv infections and aids related symptoms
10/16/2002	EP1248518A2 Transgenic mouse model of human neurodegenerative disease
10/16/2002	EP1248517A2 Clonal propagation of primate offspring by embryo splitting
10/16/2002	EP1248516A2 38 human secreted proteins
10/16/2002	EP1135527B1 Cloning and copying on surfaces
10/16/2002	EP1108062A4 Use of pooled probes in genetic analysis
10/16/2002	EP1019417B1 Phospholipid analogue compounds
10/16/2002	EP1017785A4 Rna export element and methods of use
10/16/2002	EP1009861A4 Gene expression and evaluation system
10/16/2002	EP0988383B1 Fumonisin detoxification compositions and methods
10/16/2002	EP0977836A4 Leafy cotyledon1 genes and their uses
10/16/2002	EP0973794B1 Netrin receptors
10/16/2002	EP0831919B1 Method for pharmaceutical delivery by gene therapy
10/16/2002	EP0774001B1 Production of tissue factor pathway inhibitor
10/16/2002	EP0750669B1 MODIFIED PAPILLOMA VIRUS L2 PROTEIN AND VLPs FORMED THEREFROM
10/16/2002	EP0746622B1 Antifungal proteins, dna coding therefor, and hosts incorporating same
10/16/2002	EP0728205B1 Reagent for treatment of arthritic conditions
10/16/2002	EP0672128B1 Stem cell proliferation factor
10/16/2002	EP0670847B1 Subtilin variant of enhanced stability and activity
10/16/2002	EP0639225B1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
10/16/2002	EP0637965B1 Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
10/16/2002	EP0619742B1 Transfection of lung via aerosolized transgene delivery
10/16/2002	EP0523187B1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
10/16/2002	CN1375012A Trap vector and gene trapping method by using the same

1 ... 2687 2688 2689 2690 2691 2692 2693 2694 2695 2696 2697 2698 2699 2700 2701 2702 2703 2704 2705 2706 2707 ... 4023